Radar · Healthcare in Massachusetts
Best Healthcare Companies in Massachusetts, United States
The 1192 best Healthcare companies in Massachusetts, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Shields Health Solutions.
By Rohit KhannaTrends & Stories
1192companies tracked
$19.3Bdisclosed funding
0unicorns
298have raised
Ranked: Best Healthcare companies in Massachusetts
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Shields Health Solutions Provider of pharmacy acceleration services | $3.5B | 9 mo ago | 2,000 | — | WordPress Block EditorUnbounceWordPress+28 | — | — |
| 2 | Steward Physician-led integrated healthcare network provider 32Funding top 24%Market top 42%Tech top 43%Talent top 45% All 10 signals ▾Fundingtop 24% Markettop 42% Techtop 43% Talenttop 45% Newsbottom 42% Moatbottom 42% Globalbottom 32% Growthbottom 29% Innovationbottom 19% Patentsbottom 19% Funding: Raised $1.2B · 5 rounds over 16 yrs (0.3/yr) Market: 24,780 employees (top 12% of Hospital Chains) · Top-5,000,000 web property rank vs industry peers · Fliar Intelligence Index 32/100 | $1.2B | 28 mo ago | 24,780 | Armin Ernst Md Mhcm CEO and President | SentryApple iCloud MailMicrosoft 365+15 | 2 patents Integrated common‑mode choke designs for EMI suppression in power‑electronics modules | — |
| 3 | Curaleaf Brand of cannabis dispensary | $785M | 17 mo ago | 5,931 | — | WordPressMySQLPHP+30 | 10 patents Cannabis extraction methods, formulation chemistry, and child‑proof dosing devices. | — |
| 4 | Broad Institute R&D focused on development of drugs | $762M | 5 mo ago | 2,033 2,033 → 3,206 (+58%) | — | SentryApple iCloud MailGoogle Workspace+21 | — | 1 expansion |
| 5 | Agenusbio Developer of immunotherapies to treat cancer 60Funding top 20%Tech top 34%Product top 35%Market top 37% All 11 signals ▾Fundingtop 20% Techtop 34% Producttop 35% Markettop 37% Moattop 44% Partnerstop 45% Fin. healthtop 48% Growthtop 50% Newsbottom 47% Talentbottom 40% Globalbottom 39% Funding: Raised $441M across 12 rounds · 12 rounds over 17 yrs (0.7/yr) Tech: 41 technologies across 6/8 capability areas · Cloud: Cloudflare, Fastly rank vs industry peers · Fliar Intelligence Index 60/100 | $441M | 12 mo ago | 533 | Garo Armen Chairman & CEO | WordPressMySQLMariaDB+19 | — | — |
| 6 | BNHC Brockton Neighborhood Health Center renders mental health, disorder treatment, nephrology, endocrinology… 62Funding top 22%Growth top 35%Market top 46%Tech bottom 33% All 5 signals ▾Fundingtop 22% Growthtop 35% Markettop 46% Techbottom 33% Globalbottom 33% Funding: Raised $362M across 36 rounds · 36 rounds over 19 yrs (1.9/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 62/100 | $362M | 9 mo ago | 278 | — | WordPress Block EditorWordPressApple iCloud Mail+18 | — | — |
| 7 | UMass Health system 55Funding top 25%Market top 42%Growth bottom 46%Tech bottom 40% All 6 signals ▾Fundingtop 25% Markettop 42% Growthbottom 46% Techbottom 40% Moatbottom 38% Globalbottom 32% Funding: Raised $263M across 88 rounds · 88 rounds over 20 yrs (4.4/yr) Market: 9,422 employees (top 24% of Hospital Chains) · Top-500,000 web property rank vs industry peers · Fliar Intelligence Index 55/100 | $263M | 24 mo ago | 9,422 9,422 → 7,300 (-23%) | — | DrupalMariaDBPHP+21 | — | — |
| 8 | Community Health Connections Multi-site community health center providing urgent, primary, and specialized care 57Funding top 32%Growth top 35%Market top 46%Talent bottom 45% All 6 signals ▾Fundingtop 32% Growthtop 35% Markettop 46% Talentbottom 45% Techbottom 36% Globalbottom 33% Funding: Raised $255M across 23 rounds · 23 rounds over 19 yrs (1.2/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $255M | 12 mo ago | 179 | John Demalia President and CEO | PHPMediaElement.jsGSAP+11 | — | 1 job opening · 1 expansion · 1 award |
| 9 | Affinia Therapeutics Develops Adeno-associated viruses(AAV) for gene therapy | $218M | 9 mo ago | 64 | Rob Aboud Co-Founder and Chief Legal Officer | — | — | — |
| 10 | VIZGEN Developer of solutions for healthcare data analytics and single-cell gene expression profiling | $188M | 5 mo ago | 201 | Xiaowei Zhuang Co-Founder | WordPressSentryApple iCloud Mail+38 | 12 patents Spatial nucleic acid imaging and multiplexed FISH probe anchoring technologies | 3 launchs · 2 awards |
| 11 | Eleanor Health Chain of addiction and mental health treatment centers 55Funding top 18%Moat top 22%Growth top 35%Talent top 45% All 8 signals ▾Fundingtop 18% Moattop 22% Growthtop 35% Talenttop 45% Techtop 46% Marketbottom 41% Newsbottom 31% Globalbottom 29% Funding: Raised $166M across 6 rounds · 6 rounds over 7 yrs (0.9/yr) Moat: Editorial + unicorn rating 8/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 55/100 | $166M | 20 mo ago | 203 | Nzinga Harrison Co-Founder & Chief Medical Officer | WordPress Block EditorWordPressSentry+21 | — | — |
| 12 | Superluminal Medicines Generative biological and chemical company focused on drug discovery 57Funding top 21%Talent top 38%Market bottom 44%Partners bottom 35% All 6 signals ▾Fundingtop 21% Talenttop 38% Marketbottom 44% Partnersbottom 35% Globalbottom 29% Newsbottom 15% Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 57/100 | $153M | 10 mo ago | — | Ajay Yekkirala Co-Founder | — | — | — |
| 13 | Alira Health Provider of advisory services, healthcare IT, market access, regulatory affairs, and other services | $133M | 17 mo ago | 116 | Gabriele Brambilla Co-Founder & Co-CEO | WordPressApple iCloud MailMicrosoft 365+21 | — | — |
| 14 | AXONIS Therapeutics Provider of drug discovery services | $124M | 16 mo ago | 14 | Joanna Stanicka Co-Founder & CEO | WordPressMySQLPHP+16 | — | — |
| 15 | Alloy Therapeutics Provider of drug discovery services 60Funding top 20%News top 32%Growth top 37%Tech top 39% All 8 signals ▾Fundingtop 20% Newstop 32% Growthtop 37% Techtop 39% Talentbottom 49% Marketbottom 38% Moatbottom 38% Globalbottom 37% Funding: Raised $117M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) News: 3 BI events in 12 mo (of 14 tracked, 5 types) · Top themes: Funding, Capital raise, M&A rank vs industry peers · Fliar Intelligence Index 60/100 | $117M | 2 mo ago | 130 | Errik Anderson CEO | WordPressApple iCloud MailGoogle Workspace+32 | — | 1 job opening · 1 partnership |
| 16 | Outercape Outer Cape Health Services provides healthcare and supportive social services that promote health and… | $117M | 11 mo ago | 120 | — | WordPress Block EditorWordPressMySQL+16 | — | — |
| 17 | EdenRoc R&D company focused on manufacturing of drugs for multiple therapeutic areas | $100M | 19 mo ago | 12 | — | — | — | — |
| 18 | Wellness Pet Provider of natural pet food services | $100M | 12 mo ago | 435 | Reed Howlett CEO | WordPress Block EditorWordPressApple iCloud Mail+26 | — | 6 job openings · 1 award |
| 19 | Pillar Biosciences NGS solutions provider driving accessible, actionable results for medical care providers | $91M | 12 mo ago | 84 | Zhaohui Wang Co-Founder | — | — | 1 partnership |
| 20 | Imbria Pharmaceuticals Provider of therapeutics solution by translation the cellular metabolism | $90M | 7 mo ago | 4 | David-Alexandre Gros Co-Founder & CEO | — | 161 patents Metabolic-modulating small molecules for cardiac, renal, and fibrotic disease therapy | — |
| 21 | Mercy BioAnalytics Manufacturer of diagnostic test devices | $68M | 9 mo ago | 18 | Joseph Sedlak Co-Founder & CSO | — | 87 patents Molecular diagnostic assays and biomarkers for early cancer detection | 2 job openings · 2 launchs |
| 22 | Hyku Biosciences Covalent medicines platform for expanding the boundaries of drug discovery 57Funding top 33%Talent bottom 49%Global bottom 38%News bottom 18% All 4 signals ▾Fundingtop 33% Talentbottom 49% Globalbottom 38% Newsbottom 18% Funding: Raised $56.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 57/100 | $56M | 6 mo ago | — | Kleem Chaudhary President & Chief Executive Officer | — | — | — |
| 23 | Viva Tides Manufacturer of oligonucleotides therapeutics | $54M | 2 mo ago | — | Keming Zhou Founder & CEO | — | — | — |
| 24 | Manifold Bio Developer of tissue-targeted therapeutics using in vivo screening and AI design 29Funding top 34%Talent top 45%Moat bottom 38%Global bottom 37% All 5 signals ▾Fundingtop 34% Talenttop 45% Moatbottom 38% Globalbottom 37% Marketbottom 26% Funding: Raised $45.4M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 29/100 | $45M | 18 mo ago | 22 | Gleb Kuznetsov Co-Founder & CEO | — | — | — |
| 25 | TigaTx Provider of cancer drugs development services | $37M | 17 mo ago | 3 | Anne Altmeyer CEO | — | 24 patents Therapeutic antibody engineering for oncology, focusing on CD20, IgA, anti‑GD2 and bispecific T‑cell engagers | — |
| 26 | Axena Health Standalone women fitness centre | $36M | 5 mo ago | 30 | Jayashankar Das Founder & CEO | — | — | — |
| 27 | Cartwheel Mental health partner for K-12 school districts offering personalized support by licensed clinicians 57Funding top 25%Tech top 33%Growth top 35%Talent top 38% All 6 signals ▾Fundingtop 25% Techtop 33% Growthtop 35% Talenttop 38% Marketbottom 28% Globalbottom 25% Funding: Raised $35.2M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Tech: 32 technologies across 6/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 57/100 | $35M | 10 mo ago | — | Daniel Tartakovsky Co-Founder | WebflowCart FunctionalitySplide+19 | — | 2 partnerships |
| 28 | Animol Discovery R&D company focused on manufacturing drugs for multiple therapeutic areas | $34M | 17 mo ago | 20 | Philip Austin Co-founder and Member of Board of Directors | — | 11 patents Veterinary drugs: canine JAK inhibitors and antiparasitic cyclic depsipeptide therapeutics. | — |
| 29 | Grouper Provider of fitness services | $29M | 9 mo ago | — | Spencer Morgan Founder | WordPressApple iCloud MailGoogle Workspace+24 | — | — |
| 30 | Harvard Apparatus Regenerative Technology Biotechnology company using a patient's own stem cells to regenerate organ tissue | $29M | 5 mo ago | 8 | Jerry He Chairman and CEO | WordPressMySQLPHP+19 | 33 patents Bioengineered scaffolds and devices for in vivo regeneration of hollow tubular organs | — |
| 31 | PIH Health organization aims to fights social injustice by bringing the benefits of modern medical science | $25M | 16 mo ago | 335 | Ophelia Dahl Co-Founder | DrupalPHPJava+39 | — | — |
| 32 | Knownwell Provider of primary care, behavioral health, and nutrition counseling services at home | $24M | 8 mo ago | 4 | Brooke Pratt Co-Founder & CEO | WebflowAmazon Web ServicesTypekit+20 | — | — |
| 33 | Neutrolis R&D company focused on manufacturing of drugs for multiple therapeutic areas | $23M | 15 mo ago | 9 | Abdul Hakkim Co-Founder | WebflowSendgridMicrosoft 365+7 | 91 patents Engineered DNase enzymes for therapeutic and industrial nucleic acid degradation applications | — |
| 34 | Goodpath Provider of healthcare plans for back pain, sleep, and IBS issues 55Funding top 34%Growth top 35%Tech top 35%Global top 45% All 8 signals ▾Fundingtop 34% Growthtop 35% Techtop 35% Globaltop 45% Talentbottom 49% Productbottom 48% Marketbottom 37% Customersbottom 5% Funding: Raised $22.0M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 10 mo ago | 44 | Bill Gianoukos Founder & CEO | ContentfulSentryZendesk+22 | — | 3 job openings |
| 35 | Oryon Developer of autologous neuron replacement medicines for neurodegenerative disorders 50Talent top 28%Funding top 45%Innovation top 49%Patents top 49% All 5 signals ▾Talenttop 28% Fundingtop 45% Innovationtop 49% Patentstop 49% Globalbottom 42% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $21.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $21M | 2 mo ago | — | Ole Isacson Co-Founder | — | 20 patents Electroluminescent lighting and flexible EL display technologies with nano‑engineered phosphor layers | — |
| 36 | Nexcure Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers | $19M | 3 mo ago | — | Anish More Co-Founder & CBO | — | — | — |
| 37 | Dash Bio Provider of automated bioanalysis platform for accelerated clinical drug development 40Talent top 38%Funding top 39%Global bottom 33% All 3 signals ▾Talenttop 38% Fundingtop 39% Globalbottom 33% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $17.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $18M | 12 mo ago | — | Ander Tallett Co-Founder & COO | — | — | — |
| 38 | TissueVision Innovating whole tissue imaging and analysis solutions for life-saving therapies 22Patents top 40%Funding top 43%Moat top 45%Innovation top 48% All 7 signals ▾Patentstop 40% Fundingtop 43% Moattop 45% Innovationtop 48% Techbottom 42% Globalbottom 37% Marketbottom 26% Patents: 41 patents matched (strict assignee match) · 9 filings since 2022 vs 15 in 2017-21 Funding: Raised $13.4M across 15 rounds · 15 rounds over 17 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 22/100 | $13M | 12 mo ago | 17 | — | — | 41 patents Automated digital pathology: tissue section handling, indexing, multiplex imaging, and serial staining. | — |
| 39 | Orthogon Therapeutics Developing a pipeline of therapeutics for a range of disease indications | $12M | 2 mo ago | 3 | Ali Munawar Founding CEO | — | — | — |
| 40 | 2Pi Optics Manufacturer of optical metasurfaces 22Funding top 29%Talent bottom 45%Global bottom 29%Market bottom 25% All 4 signals ▾Fundingtop 29% Talentbottom 45% Globalbottom 29% Marketbottom 25% Funding: Raised $12.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 22/100 | $12M | 8 mo ago | 7 | Mikhail Shalaginov Co-Founder & CSO | — | — | — |
| 41 | Lytica Therapeutics Developer of therapeutic drugs | $12M | 15 mo ago | 10 | Jim LaTorre CEO | — | — | — |
| 42 | Carna Health Company that provides integrated point-of-care testing solutions and AI-powered technology | $11M | 5 mo ago | — | Salvatore Viscomi Co-Founder & CEO | WebflowYouTubeMicrosoft Advertising+12 | — | 1 award |
| 43 | Silent Spring Institute Researcher of environmental causes of breast cancer | $11M | 12 mo ago | 32 | — | DrupalMariaDBPHP+20 | — | — |
| 44 | STRM.BIO R&D company focused on manufacturing gene therapy diagnostic tests for multiple therapeutic areas | $10M | 5 mo ago | 23 | Jonathan Thon Founder | — | — | 1 launch |
| 45 | Lifordi Biotechnology company developing treatments for autoimmune and inflammatory disorders using antibody-drug… 45Funding top 45%Talent bottom 49%Global bottom 36% All 3 signals ▾Fundingtop 45% Talentbottom 49% Globalbottom 36% Funding: Raised $5.9M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 45/100 | $6M | 6 mo ago | — | Arthur Tzianabos CEO | — | — | — |
| 46 | MAKScientific Targeting the endocannabinoid system for the treatment of metabolic disorders, pain, addiction, and… | $6M | 13 mo ago | — | Alexandros Makriyannis Co-Founder | — | 22 patents Therapeutic small‑molecule drugs and formulations for addiction, cannabinoid toxicity, and fibrosis | — |
| 47 | FamilyWell Health Provider of integrated perinatal mental health services for OB clinics. 45Growth top 28%Funding top 41%Tech top 50%Talent bottom 49% All 7 signals ▾Growthtop 28% Fundingtop 41% Techtop 50% Talentbottom 49% Moatbottom 38% Globalbottom 29% Marketbottom 27% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $4.3M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $4M | 6 mo ago | — | Jessica Gaulton Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+19 | — | — |
| 48 | Protein Dynamic Solutions Transforming protein analytics for better biotherapeutics, enhancing regulatory compliance 42Patents top 25%Innovation top 26%Talent top 28%Moat top 32% All 7 signals ▾Patentstop 25% Innovationtop 26% Talenttop 28% Moattop 32% Fundingtop 48% Globalbottom 35% Marketbottom 14% Patents: 55 patents matched (strict assignee match) · 34 filings since 2022 vs 21 in 2017-21 Innovation: 55 patents (top 29% of patent-holders) · 34 filings since 2022 vs 21 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 10 mo ago | 9 | William Lockwood-Benet Co-Founder | — | 55 patents Analytical methods for protein deamidation, immunogenicity, purity, and epitope mapping | 1 launch |
| 49 | Sunflower Therapeutics Provider of drug development & research services for multiple therapeutic areas | $3M | 9 mo ago | 10 | — | — | — | 1 launch |
| 50 | EMBioSys Developer of non-invasive wearable technology for induced electric field cancer therapy | $2M | 6 mo ago | — | Vish Subramaniam Co-Founder & CSO | — | — | — |
Top 12 Healthcare companies in Massachusetts
#1
Funding Raised · Cambridge, Massachusetts · founded 2003 · 2033 employees$762.1Mraised▾
Funding Raised · Cambridge, Massachusetts · founded 2003 · 2033 employees
R&D focused on development of drugs
LinkedIn Pulse recent public activity · Jul 2026
Audience: 168k LinkedIn followers — 19.5% of this cohort's audience · 106 engagements/post (4.8× cohort median)
Activity: 1 expansions announced in 12 mo
Funding rounds
- Dec 2025Grant (prize money)$1.6M
- Dec 2025Grant (prize money)$16.6M
- Dec 2025Grant (prize money)$158K
- Dec 2025Grant (prize money)$6.9M
Investors
Europa, HHS, United States Department of Agriculture, National Science Foundation, Military Health
Tech stack
Acquia Cloud PlatformAcquia Cloud Platform CdnAddtoanyAmazon S3Amazon Web ServicesApache Http Server
#2
Acquired · Stoughton, Massachusetts · founded 2012 · 2000 employees$3.5Braised▾
Acquired · Stoughton, Massachusetts · founded 2012 · 2000 employees
Provider of pharmacy acceleration services
LinkedIn Pulse recent public activity · Jul 2026
Audience: 31k LinkedIn followers — 3.5% of this cohort's audience
Funding rounds
- Sep 2025Series B$3.5B
- Jul 2019Series A—
Investors
Welsh, Carson, Anderson & Stowe, Walgreens, Evernorth, Intermountain Ventures, Shields Capital, Oxeon Partners
Tech stack
6SenseAmazon S3Amazon Web ServicesCdnjsCloudflareCloudflare Bot Management
#3
Series E · Lexington, Massachusetts · founded 2017 · 130 employees$117Mraised▾
Series E · Lexington, Massachusetts · founded 2017 · 130 employees
Provider of drug discovery services
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 20%News
top 32%Growth
top 37%Tech
top 39%Talent
bottom 49%Market
bottom 38%Funding: Raised $117M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) · Last round Series E (Mar 2026)
News: 3 BI events in 12 mo (of 14 tracked, 5 types) · Top themes: Funding, Capital raise, M&A
Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo
Audience (LinkedIn): 26k LinkedIn followers — 3.0% of this cohort's audience · 60 engagements/post (2.7× cohort median)
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Director, Partnerships Office
Activity (LinkedIn): 1 partnerships (incl. Voro Therapeutics) announced in 12 mo
Funding rounds
- Mar 2026Series E$40M
- Oct 2022Series D$42M
- Apr 2021Series C$75M
Founders & team
Investors
8VC, Presight Capital, Mubadala, Alexandria, Founders Fund, Ulysses Diversified Holdings
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCookiebotCore-JsDocusign
#4
Series E · Cambridge, Massachusetts · founded 2019 · 201 employees$187.7Mraised▾
Series E · Cambridge, Massachusetts · founded 2019 · 201 employees
Developer of solutions for healthcare data analytics and single-cell gene expression profiling
LinkedIn Pulse recent public activity · Jul 2026
Audience: 19k LinkedIn followers — 2.2% of this cohort's audience
Activity: 3 product launches · 2 awards announced in 12 mo
Funding rounds
- Dec 2025Series E$48M
- Oct 2025Conventional Debt$3.5M
- Mar 2024Series C—
- Apr 2022Series C$85.2M
Founders & team
Investors
Arch Venture Partners, Northpond Ventures, Novalis LifeSciences, Tao Capital Partners, Pura Vida Investments, Blue Water Life Science Advisors
Tech stack
Amazon S3Amazon Web ServicesAosApple Icloud MailCdnjsCloudflare
#5
Funding Raised · Brockton, Massachusetts · founded 1992 · 278 employees$361.9Mraised▾
Funding Raised · Brockton, Massachusetts · founded 1992 · 278 employees
MissionBrockton Neighborhood Health Center is a multicultural organization that collaborates with community agencies and residents to provide high quality comprehensive health care that is responsive to community health needs and is linguistically, culturally and financially accessible. We are committed to health promotion and disease prevention.
Fliar Intelligence Index™ 62how this company ranks against its industry peers
Funding
top 22%Growth
top 35%Market
top 46%Tech
bottom 33%Global
bottom 33%Funding: Raised $362M across 36 rounds · 36 rounds over 19 yrs (1.9/yr) · Last round Grant (prize money) (Sep 2025)
Growth: Fresh capital in last 24 mo
Market: 278 employees (top 25% of Clinics) · Top-10,000,000 web property
Audience (LinkedIn): 2k LinkedIn followers
Funding rounds
- Sep 2025Grant (prize money)$150K
- Jun 2025Grant (prize money)$33.9M
- 2025Grant (prize money)$3.3M
- May 2025Grant (prize money)$132.5K
Investors
HRSA, HHS
Tech stack
Apple Icloud MailAudioeyeBootstrapCore-JsGodaddyGoogle Font Api
#6
Series A · Woburn, Massachusetts · founded 2025$54Mraised▾
Series A · Woburn, Massachusetts · founded 2025
Manufacturer of oligonucleotides therapeutics. It specializing in developing extrahepatic RNA-targeting therapeutics. The company aims to overcome traditional limitations by delivering siRNA and antisense oligonucleotides to tissues beyond the liver, such as muscles and the nervous system, for treating chronic diseases.
Funding rounds
- Apr 2026Series A$54M
Founders & team
Investors
Qiming Venture Partners, Hlc Fund, TF Capital, Apricot Capital
#7
Series C · Waltham, Massachusetts · founded 2019 · 64 employees$218.3Mraised▾
Series C · Waltham, Massachusetts · founded 2019 · 64 employees
Develops Adeno-associated viruses(AAV) for gene therapy
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers
Funding rounds
- Sep 2025Series C$40M
- Apr 2021Series B$110M
- Mar 2020Series A$60M
- Oct 2019Seed$8.3M
Founders & team
Investors
F-Prime Capital, New Enterprise Associates, Atlas Venture, Lonza, Alexandria, Partners Health Care Innovation
#8
Public · Lexington, Massachusetts · founded 1994 · 533 employees$440.7Mraised▾
Public · Lexington, Massachusetts · founded 1994 · 533 employees
Developer of immunotherapies to treat cancer. The company's portfolio consists of bio-engineered therapies targeting complementary mechanisms to fight cancer, including checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 20%Tech
top 34%Product
top 35%Market
top 37%Moat
top 44%Partners
top 45%Funding: Raised $441M across 12 rounds · 12 rounds over 17 yrs (0.7/yr) · Last round Post IPO (Jun 2025)
Tech: 41 technologies across 6/8 capability areas · Cloud: Cloudflare, Fastly · Devops: Nginx, Varnish
Product: 0 product launch events in 12 mo · Company stage: Public
Audience (LinkedIn): 45k LinkedIn followers — 5.2% of this cohort's audience
Funding rounds
- Jun 2025Post IPO—
- Jul 2020Post IPO$35M
- Jan 2019Post IPO$30M
- Oct 2018Post IPO$40M
Founders & team
Investors
Betta Pharmaceuticals, HealthCare Royalty Partners, Incyte, Zynext Ventures, Grazia Equity, Advent Life Sciences
Tech stack
CloudflareComplianzDocusignElementorFancyboxFastly
#9
Series B · Boston, Massachusetts · founded 2014 · 4 employees$90.2Mraised▾
Series B · Boston, Massachusetts · founded 2014 · 4 employees
Imbria Pharmaceuticals provides therapeutics solution by translation the cellular metabolism. It is involved in providing transformative medicine, by altering the cellular metabolism and mitochondrial function.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers
Funding rounds
- Nov 2025Series B—
- Mar 2025Series B$66.7M
- Jul 2019Series B$50M
- Jul 2018Series B$40.2M
Founders & team
Investors
RA Capital Management, Sanofi Ventures, Deep Track Capital, AN Venture Partners, Catalio Capital Management, Cytokinetics
#10
Series A · Braintree, Massachusetts · founded 2012 · 3 employees$12.5Mraised▾
Series A · Braintree, Massachusetts · founded 2012 · 3 employees
Developing a pipeline of therapeutics for a range of disease indications
Funding rounds
- Apr 2026Series A$11M
- Dec 2024Series A$5.2M
- Nov 2021Series A$8M
- Mar 2018Series A$4.4M
Founders & team
Investors
Healthcare Angels, otrfoundation
#11
Series A · Belmont, Massachusetts · founded 2020$21Mraised▾
Series A · Belmont, Massachusetts · founded 2020
Developer of autologous neuron replacement medicines for neurodegenerative disorders. The company focuses on developing medicines to replace lost neurons. It aims to restore function for Parkinson’s disease and other neurodegenerative disorders.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Talent
top 28%Funding
top 45%Innovation
top 49%Patents
top 49%Global
bottom 42%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Funding: Raised $21.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Mar 2026)
Innovation: 20 patents (top 51% of patent-holders)
Funding rounds
- Mar 2026Grant (prize money)—
- Mar 2026Series A$21M
Founders & team
Investors
Byers Capital, Neuro VC
#12
Public · Holliston, Massachusetts · founded 2012 · 8 employees$28.5Mraised▾
Public · Holliston, Massachusetts · founded 2012 · 8 employees
HRGN is a clinical-stage biotechnology company that specializes in regenerating organ tissue using a patient's own stem cells grown on a scaffold. They are focused on developing innovative solutions for patients with damaged organs due to cancer, trauma, birth defects, or other diseases. The company is led by an experienced team with a background in biotechnology, patient care, finance, and new product development.
Funding rounds
- Dec 2025Post IPO$700K
- Jul 2025Post IPO$2M
- Apr 2024Post IPO$1.5M
- Apr 2023Post IPO$6M
Founders & team
Investors
Connecticut Children’s Medical Center, HHS
Funding & investor landscape
$19.3Btotal disclosed funding
283companies funded
1,105disclosed rounds
5rounds last 90 days
Most active investors
Atlas Venture9 rounds
Notable founders
Errik Anderson
CEO · Alloy Therapeutics
Xiaowei Zhuang
Co-Founder · VIZGEN
George Emanuel
Co-Founder · VIZGEN
Keming Zhou
Founder & CEO · Viva Tides
Rob Aboud
Co-Founder and Chief Legal Officer · Affinia Therapeutics
Rick Modi
Co-Founder & CEO · Affinia Therapeutics
Garo Armen
Chairman & CEO · Agenusbio
David-Alexandre Gros
Co-Founder & CEO · Imbria Pharmaceuticals
Andrew Levin
Co-Founder · Imbria Pharmaceuticals
Ali Munawar
Founding CEO · Orthogon Therapeutics
Ole Isacson
Co-Founder · Oryon
Nikola Kojic
Co-Founder & Chief Innovation Officer · Oryon
Prism market signals · United States · country-scoped Prism corpus, 13,358,462 docs
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Healthcare companies are there in Massachusetts, United States?
Radar tracks 1192 indexable Healthcare companies headquartered in Massachusetts, United States that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Massachusetts, United States?
The Healthcare companies in Massachusetts, United States on this list have raised a combined $19.3B in disclosed equity funding across 283 funded companies.
Which is the highest-funded Healthcare company in Massachusetts, United States?
Shields Health Solutions is the highest-funded Healthcare company in Massachusetts, United States, with $3.5B in disclosed equity funding.
How many Healthcare companies in Massachusetts, United States are funded?
283 of the 1192 Healthcare companies in Massachusetts, United States on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Massachusetts, United States?
None of the Healthcare companies in Massachusetts, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Massachusetts, United States Healthcare companies?
The most active investors in Massachusetts, United States Healthcare companies on this list include HHS, MassChallenge, Europa, HRSA, Massachusetts Biomedical Initiatives.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.